G16V (p.Gly16Val) variant of SLC35A2 (UDP-galactose translocator)

G16V (p.Gly16Val) in SLC35A2 (UDP-galactose translocator) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance in the context of in CDG2M. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes population frequency data and structural context.

G16V (p.Gly16Val) variant details